Drug Profile


Latest Information Update: 16 Oct 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator GlaxoSmithKline
  • Class Antimalarials; Antiprotozoals; Diamines; Pyrimidines
  • Mechanism of Action Tetrahydrofolate dehydrogenase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase I Toxoplasmosis

Most Recent Events

  • 25 Sep 2017 Phase-I clinical trials in Toxoplasmosis in Australia (PO) (NCT03258762)
  • 12 Sep 2017 Chemical structure information added
  • 21 Aug 2017 GlaxoSmithKline plans a phase I trial for toxoplasmosis (In Japanese and Caucasian volunteers) in September 2017 (NCT03258762)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top